Telotristat Etiprate for Carcinoid Syndrome: A Single-Arm, Multicenter Trial

Journal of Clinical Endocrinology and Metabolism - Tập 100 Số 4 - Trang 1511-1519 - 2015
Marianne Pavel1, Dieter Hörsch2, Martyn Caplin3, John Buscombe4, Thomas Seufferlein5, Juan W. Valle6, Phillip Banks7, Pablo Lapuerta8, Arthur Sands8, Brian Zambrowicz8, Douglas Fleming8, Bertram Wiedenmann1
1Charité – Universitätsmedizin (M.P., B.W.), Department of Gastroenterology and Hepatology, 13353 Berlin Germany
2 Zentralklinik Bad Berka GmbH (D.H.), Department of Gastroenterology and Endocrinology, 99437 Bad Berka, Germany
3 Royal Free London National Health Service (NHS) Foundation Trust (M.C.), Department of Gastroenterology and Hepatobiliary Medicine, London NW3 2QG, United Kingdom
4 Basingstoke and North Hampshire NHS Foundation Trust (J.R.), Department of Gastroenterology, Hampshire RG24 9NA, United Kingdom
5 Ulm University (T.S.), Department of Internal Medicine I, 89070 Ulm, Germany
6The University of Manchester/The Christie NHS Foundation Trust (J.V.), Department of Medical Oncology, Manchester M20 4BX, United Kingdom
7 and Lexicon Pharmaceuticals, Inc (P.B., P.L., A.S., B.Z., D.F.), Department of Clinical Development, The Woodlands, Texas 77381.
8Lexicon Pharmaceuticals, Inc (P.B., P.L., A.S., B.Z., D.F.), Department of Clinical Development, The Woodlands, Texas 77381

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Journal of Clinical Endocrinology and Metabolism

Tập 100 Số 4

1511-1519

Thông tin tác giả